SG10202007867PA - Cancer epigenetic profiling - Google Patents
Cancer epigenetic profilingInfo
- Publication number
- SG10202007867PA SG10202007867PA SG10202007867PA SG10202007867PA SG10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA SG 10202007867P A SG10202007867P A SG 10202007867PA
- Authority
- SG
- Singapore
- Prior art keywords
- epigenetic profiling
- cancer
- cancer epigenetic
- profiling
- epigenetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201601141X | 2016-02-16 | ||
SG10201606828P | 2016-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202007867PA true SG10202007867PA (en) | 2020-09-29 |
Family
ID=59625365
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202007867PA SG10202007867PA (en) | 2016-02-16 | 2017-02-16 | Cancer epigenetic profiling |
SG11201806945SA SG11201806945SA (en) | 2016-02-16 | 2017-02-16 | Cancer epigenetic profiling |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201806945SA SG11201806945SA (en) | 2016-02-16 | 2017-02-16 | Cancer epigenetic profiling |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210223249A1 (ja) |
EP (1) | EP3417076B1 (ja) |
JP (2) | JP7189020B2 (ja) |
KR (1) | KR20180108820A (ja) |
CN (1) | CN109072312A (ja) |
SG (2) | SG10202007867PA (ja) |
WO (1) | WO2017142485A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108085395A (zh) * | 2018-02-24 | 2018-05-29 | 韩林志 | 基于高通量测序的宫颈癌多基因甲基化检测的引物组、试剂盒及方法 |
CN109735539B (zh) * | 2019-01-22 | 2022-06-03 | 南通大学 | 一种基于pdl1/pdl2超增强子的调控pdl1和pdl2表达的控方法 |
CN112111576A (zh) * | 2020-09-29 | 2020-12-22 | 杨帆 | 用于筛查鼻咽癌的方法及应用 |
CN114164210B (zh) * | 2021-08-19 | 2023-10-10 | 上海海洋大学 | 一种调控原癌基因myb的长链非编码rna及其应用 |
CN114525249A (zh) * | 2022-03-31 | 2022-05-24 | 广西大学 | 一种用于分离牛肌肉干细胞的肌肉组织提取方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2470170A4 (en) * | 2009-08-25 | 2013-01-02 | Harvard College | USE OF METFORMIN IN THE TREATMENT AND PREVENTION OF CANCER |
US20140287932A1 (en) | 2012-10-25 | 2014-09-25 | Whitehead Institute For Biomedical Research | Super-enhancers and methods of use thereof |
CN106103739B (zh) * | 2013-12-30 | 2019-12-06 | 新加坡科技研究局 | 用于测量胃肠癌中的生物标记物的方法 |
US20190005191A1 (en) * | 2015-07-14 | 2019-01-03 | Whitehead Institute For Biomedical Research | Chromosome neighborhood structures and methods relating thereto |
-
2017
- 2017-02-16 WO PCT/SG2017/050073 patent/WO2017142485A1/en active Application Filing
- 2017-02-16 SG SG10202007867PA patent/SG10202007867PA/en unknown
- 2017-02-16 CN CN201780023350.1A patent/CN109072312A/zh active Pending
- 2017-02-16 EP EP17753596.0A patent/EP3417076B1/en active Active
- 2017-02-16 KR KR1020187026079A patent/KR20180108820A/ko unknown
- 2017-02-16 US US15/999,378 patent/US20210223249A1/en not_active Abandoned
- 2017-02-16 JP JP2018543192A patent/JP7189020B2/ja active Active
- 2017-02-16 SG SG11201806945SA patent/SG11201806945SA/en unknown
-
2022
- 2022-12-01 JP JP2022193109A patent/JP2023029945A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7189020B2 (ja) | 2022-12-13 |
KR20180108820A (ko) | 2018-10-04 |
WO2017142485A1 (en) | 2017-08-24 |
CN109072312A (zh) | 2018-12-21 |
JP2023029945A (ja) | 2023-03-07 |
EP3417076B1 (en) | 2022-11-09 |
EP3417076A1 (en) | 2018-12-26 |
EP3417076A4 (en) | 2019-10-23 |
JP2019514344A (ja) | 2019-06-06 |
SG11201806945SA (en) | 2018-09-27 |
US20210223249A1 (en) | 2021-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL254283A0 (en) | Molecular profiling for cancer | |
IL255217A0 (en) | Cancer neo-epitopes | |
IL254705B (en) | Combined treatment for cancer | |
HUE038541T2 (hu) | Rák kezelési módszerek | |
IL277261A (en) | Low molecular weight compounds for cancer treatment | |
HK1258319A1 (zh) | 癌症療法 | |
IL263802A (en) | Combinations of cancer treatments | |
IL263123A (en) | Cancer treatments | |
SG10202007867PA (en) | Cancer epigenetic profiling | |
GB201500584D0 (en) | Cancer biomarkers | |
GB201618358D0 (en) | Performance profiling | |
HK1251794A1 (zh) | 癌症治療 | |
GB201519734D0 (en) | Cancer therapy | |
GB201508480D0 (en) | Cancer | |
HK1254687A1 (zh) | 用於癌症的聯合療法 | |
GB2546773B (en) | Cancer | |
GB201522433D0 (en) | Cancer treatment | |
HRP20210383T8 (hr) | Kombinirana terapija za rak | |
GB201703641D0 (en) | Cancer biomarkers | |
GB201502840D0 (en) | Cancer prognostic | |
GB201608972D0 (en) | Polytape straightener | |
GB201604813D0 (en) | Methods for detecting cancer | |
GB201522573D0 (en) | Cancer therapeutics | |
GB201601248D0 (en) | Cancer therapy | |
GB201514777D0 (en) | Cancer Treatments |